|
Volumn 59, Issue 4, 2000, Pages 291-295
|
Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer
|
Author keywords
Brain metastases; Irinotecan; Non small cell lung cancer
|
Indexed keywords
CISPLATIN;
IFOSFAMIDE;
IRINOTECAN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
AGED;
ARTICLE;
BRAIN METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG RESPONSE;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
MALE;
METASTASIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RADIOSURGERY;
|
EID: 0033668063
PISSN: 00302414
EISSN: None
Source Type: Journal
DOI: 10.1159/000012185 Document Type: Article |
Times cited : (72)
|
References (13)
|